In 2008, King's researchers published a pioneering paper which was the first to challenge the idea that autistic people have little anxiety about social situations. Now it is estimated that more than 70% of people with autism will develop a mental health problem such as anxiety or depression in their lifetime - a figure that is around 25% for people who do not have autism.

Proven treatments specifically tailored to support children with autism are scarce and often one-size-fits-all, despite autism being unique to each individual. This lack of understanding and support can have profound consequences for the child, their future life as an adult, and for society at large.  

Autistic adults are half as likely to be employed as their peers and have a lower quality of life at every stage.

Despite this alarming picture, autism research is hugely underfunded and as a result, not fully understood. Improved access to treatment and emotional support tailored for people with autism is urgently needed. With support of philanthropy, our expert team within the King’s Maudsley Partnership can improve and test existing treatments as well as promising new ones that could work better for children with autism, giving them more choice and control in looking after their mental health.  

Working with families to design new interventions

Dr Matthew Hollocks, Clinical Senior Lecturer in the Institute of Psychiatry, Psychology and Neuroscience, is currently working with autistic children and their families to develop a brand-new intervention for young people with depression based on Behavioural Activation (BA).

BA is an established, common treatment for depression and anxiety in children and adults who do not have autism and the potential benefits of using these techniques for adolescents with autism has not previously been explored. Many autistic people find the most common treatment, Cognitive Behaviour Therapy (CBT) difficult to engage with because it requires a lot of talking and thinking about emotions which can often be challenging for people with autism. Focusing instead on the link between activity and mood, BA supports those who are struggling with motivation to identify activities that boost their mood and develop achievable routines which include these tasks in small, attainable steps. Working with the individual to identify activities they enjoy, this approach reinforces the benefit of participating in positive activities and removes negative patterns of behaviour to reduce symptoms of anxiety and depression.

Dr Hollocks and his team have co-designed an adapted version of BA specifically aimed to treat depression in adolescents with autism which is currently being trialled with seven young autistic individuals. Taking place over 12 weeks and using activity data collected from wearable wrist monitors, Fitbits, this intervention monitors how re-introducing personalised positive activities such as going for walks or collecting football cards can impact and improve mood.

Initial responses have been very positive. For example, one parent said the treatment has ‘helped [their child] to open up and talk more, which is really good whereas before he would very much shut down’.

By delivering the intervention online through Microsoft Teams, the new treatment is more accessible for families across the country, and in some cases could make the treatment more effective where children may find travelling a challenge, or struggle to engage with therapy face-to-face. One study participant found the treatment ‘good because you don’t have to leave your house. You can be in a relaxed environment. [In clinic] you have lots of noise around you…here, you just click.’

Impacting families across the UK

Through such new digital interventions that have been co-designed from the very earliest stages of development, King’s researchers are addressing the urgent unmet need with evidence-based, effective treatments that are proven to support young autistic people with depression. By focusing on digital solutions for autism care, our researchers will guide the UK best practice for remote delivery, ensuring families all across the country have access to treatment.

Working as a clinical-academic partnership for over 70 years, our researchers and clinicians within King’s College London and the South London & Maudsley NHS Foundation Trust have a unique opportunity to change the way the world understands and supports autistic people. As the UK’s national centre for autism clinical care, we assess and treat the nation’s most complex cases and are regularly called upon by the NHS and government bodies to shape national and international guidelines for the care of people with autism. With philanthropic support, we want to use our expertise and close clinical partnership to rapidly test new treatment discoveries and get them into clinical practice sooner.

Our vision is a world where being neurodivergent never has to be a barrier to living a fulfilling, healthy, happy life. Together, the King’s Maudsley Partnership is uniquely poised to deliver this kind of global step change in the way we understand, prevent and treat the challenges autistic people face. If you are interested in finding out more or supporting the next stage of this research, please contact jennie.meadows@kcl.ac.uk.

Research at King's like this is only made possible through the generosity of our alumni and supporter community.  Click here to find out more about how you can have a transformational impact on society by donating to King’s.